Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 3, 2025 • 5:31 PM ET

Date/Time Source News Release
01/02/2025 07:45 AM EST Newsfile Phio Pharmaceuticals Announces Publication in Clinical, Cosmetic and Investigational Dermatology
12/23/2024 01:15 PM EST Newsfile Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
12/19/2024 02:28 PM EST Newsfile Phio Pharmaceuticals Announces $1.15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
12/19/2024 07:45 AM EST Newsfile Phio Pharmaceuticals Announces Positive Safety Monitoring Committee (SMC) Recommendation to Continue to Third Dose Cohort in its Clinical Study of PH-762
12/12/2024 09:21 AM EST Newsfile Phio Pharmaceuticals Announces Publication in Frontiers in Immunology
12/10/2024 07:45 AM EST Newsfile Phio Pharmaceuticals is a Finalist for the Technology Disruptor of the Year Award
12/03/2024 07:45 AM EST Newsfile Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
11/19/2024 07:45 AM EST Newsfile Phio Pharmaceuticals Announces Completion of Enrollment in Second Cohort in Phase 1b Dose-Escalating Clinical Study
11/14/2024 05:47 PM EST Newsfile Phio Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
11/07/2024 10:00 AM EST Newsfile Phio Pharmaceuticals Announces Upcoming Presentation at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Page

Additional News

As of January 3, 2025 • 5:31 PM ET

Date/Time Source News Release
12/19/2024 09:31 AM EST 24/7 Market News A Value Creation Event to Unveil a Pivotal Corporate Milestone is a Don't Miss Situation
12/19/2024 08:14 AM EST 24/7 Market News Positive SMC Recommendation for Third Dose Cohort in Phio's Clinical Study of PH-762
11/27/2024 04:31 AM EST US Earnings Reports Expected earnings - Phio Pharmaceuticals Corp.
11/15/2024 02:48 AM EST SeekingAlpha Phio Pharmaceuticals GAAP EPS of -$1.54 beats by $2.60
08/15/2024 10:16 AM EDT SeekingAlpha Phio Pharmaceuticals GAAP EPS of -$3.62 beats by $0.52
08/01/2024 08:29 AM EDT SeekingAlpha Phio Pharmaceuticals appoints Robert Infarinato as chief financial officer
07/04/2024 09:02 AM EDT KlickAnalytics PHIO announced stock split 1-9
05/20/2024 05:14 PM EDT SeekingAlpha Phio Pharmaceuticals files for $100M mixed shelf
05/17/2024 05:02 PM EDT SeekingAlpha Phio Pharmaceuticals files for $100M mixed securities shelf
05/10/2024 05:51 AM EDT US Earnings Reports Expected earnings - Phio Pharmaceuticals Corp.
Page